Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive])…

Snowden JA, Ahmedzai SH, Ashcroft J, DSa S, Littlewood T, Low E, et al. Guidelines for supportive care in multiple myeloma 2011. Br J Haematol. 2011;154:76103.

CAS Article Google Scholar

Snowden JA, Greenfield DM, Bird JM, Bowland E, Bowcock S, Fisher A, et al. Guidelines for screening and management of late and long-term consequences of myeloma and its treatment. Br J Haematol. 2017;176:888907.

Article Google Scholar

Pratt G, Morris TC. Review of the NICE guidelines for multiple myeloma. Int J Lab Hematol. 2017;39:313.

CAS Article Google Scholar

Boland E, Eiser C, Ezaydi Y, Greenfield DM, Ahmedzai SH, Snowden JA. Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life. J Pain Symptom Manag. 2013;46:67180.

Article Google Scholar

Ahmedzai SH, Boland J. Opioids for chronic pain: molecular and genomic basis of actions and adverse effects. Curr Opin Support Palliat Care. 2007;1:11725.

Article Google Scholar

Mantyh P. Bone cancer pain: causes, consequences, and therapeutic opportunities. Pain. 2013;154:S5462.

Article Google Scholar

Boland EG, Selvarajah D, Hunter M, Ezaydi Y, Tesfaye S, Ahmedzai SH, et al. Central pain processing in chronic chemotherapy-induced peripheral neuropathy: a functional magnetic resonance imaging study. PLoS One. 2014;9:e96474.

Article Google Scholar

Kucharczyk MW, Derrien D, Dickenson AH, Bannister K. Stage-specific plasticity descending modulatory controls a rodent model cancer-induced bone pain. Cancers. 2020;12:3286

CAS Article Google Scholar

De Gregori S, De Gregori M, Ranzani GN, Allegri M, Minella C, Regazzi M. Morphine metabolism, transport and brain disposition. Metab Brain Dis. 2012;27:15.

Article Google Scholar

Greenfield DM, Boland E, Ezaydi Y, Ross RJ, Ahmedzai SH, Snowden JA, Late Effects Group (2014). Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myeloma. Bone Marrow Transpl. 2014;49:90712.

CAS Article Google Scholar

Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science. 2001;293:3115.

CAS Article Google Scholar

Lotsch J, Stuck B, Hummel T. The human mu-opioid receptor gene polymorphism 118A>G decreases cortical activation in response to specific nociceptive stimulation. Behav Neurosci. 2006;120:121824.

Article Google Scholar

Fillingim RB, Kaplan L, Staud R, Ness TJ, Glover TL, Campbell CM, et al. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain. 2005;6:15967.

CAS Article Google Scholar

Ross JR, Rutter D, Welsh K, Joel SP, Goller K, Wells AU, et al. Clinical response to morphine in cancer patients and genetic variation in candidate genes. Pharmacogenom J. 2005;5:32436.

CAS Article Google Scholar

Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, et al. Mu-opioid receptor-mediated antinociceptive responses differ in men and women. J Neurosci. 2002;22:51007.

CAS Article Google Scholar

Oertel B, Ltsch J. Genetic mutations that prevent pain: implications for future pain medication. Pharmacogenomics. 2008;9:17994.

CAS Article Google Scholar

Holtman JR Jr, Wala EP. Characterization of the antinociceptive effect of oxycodone in male and female rats. Pharamcol Biochem Behav. 2006;83:1008.

CAS Article Google Scholar

Klepstad P, Rakvag TT, Kaasa S, Holthe M, Dale O, Borchgrevink PC, et al. The 118A>G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand. 2004;48:12329.

CAS Article Google Scholar

Chou WY, Yang LC, Lu HF, Ko JY, Wang CH, Lin SH, et al. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand. 2006;50:78792.

CAS Article Google Scholar

Kharasch ED. Current concepts in methadone metabolism and transport. Clin Pharm Drug Dev. 2017;6:12534.

CAS Article Google Scholar

Campa D, Gioia A, Tomei A, Poli P, Barale R. Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clin Pharm Ther. 2008;83:55966.

CAS Article Google Scholar

Kim H, Clark D, Dionne RA. Genetic contributions to clinical pain and analgesia: avoiding pitfalls in genetic research. J Pain. 2009;10:66393.

Article Google Scholar

Peters MJ, Broer L, Willemen HLDM, Eiriksdottir G, Hocking LJ, Holliday KL, et al. Genome-wide association study meta-analysis of chronic widespread pain: evidence for involvement of the 5p15.2 region. Ann Rheum Dis. 2013;72:42736.

CAS Article Google Scholar

Cook G, Williams C, Brown JM, Cairns DA, Cavenagh J, Snowden JA, et al. High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial. Lancet Oncol. 2014;15:87485.

CAS Article Google Scholar

Cook G, Ashcroft AJ, Cairns DA, Williams CD, Brown JM, Cavenagh JD, et al. The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial. Lancet Haematol. 2016;3:e34051.

Article Google Scholar

Ahmedzai SH, Snowden JA, Ashcroft AJ, Cairns DA, Williams C, Hockaday A, et al. Patient-reported outcome results from the open-label, randomized phase III myeloma X trial evaluating salvage autologous stem-cell transplantation in relapsed multiple myeloma. J Clin Oncol. 2019;37:161728. National Cancer Research Institute Haemato-Oncology Clinical Studies Group.

CAS Article Google Scholar

Cleeland CS. The measurement of pain from metastatic bone disease: capturing the patients experience. Clin Cancer Res. 2006;12:6236s42s.

Article Google Scholar

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:36576.

CAS Article Google Scholar

Kim H, Neubert JK, San Miguel A, Xu K, Krishnaraju RK, Iadarola MJ, et al. Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain. 2004;109:48896.

Article Google Scholar

Muralidharan A, Smith MT. Pain, analgesia and genetics. J Pharm Pharm. 2011;63:1387400.

CAS Article Google Scholar

Kim H, Ramsay E, Lee H, Wahl S, Dionne RA. Genome-wide association study of acute post-surgical pain in humans. Pharmacogenomics. 2009;10:1719.

CAS Article Google Scholar

Lacroix-Fralish ML, Mogil JS. Progress in genetic studies of pain and analgesia. Annu Rev Pharm Toxicol. 2009;49:97121.

CAS Article Google Scholar

Reyes-Gibby CC, Shete S, Rakvg T, Bhat SV, Skorpen F, Bruera E, et al. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain. 2007;130:2530.

CAS Article Google Scholar

Nielsen LM, Christrup LL, Sato H, Drewes AM, Oleson AE. Genetic influences of OPRM1, OPRD1 and COMT on morphine analgesia in a multi-modal, multi-tissue human experimental pain model. Basic Clin Pharm Toxicol. 2017;121:612.

CAS Article Google Scholar

Crist RC, Clarke T-K. OPRD1 genetic variation and human disease. Handb Exp Pharm. 2018;247:13145.

CAS Article Google Scholar

Beer B, Erb R, Pavlic M, Ulmer H, Giacomuzzi S, Riemer Y, et al. Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study. PLoS One. 2013;8:e75359.

CAS Article Google Scholar

Go here to see the original:
Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive])...